Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myelogenous Leukemia
>>
Roche
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
Rituxan
(rituximab) / Roche
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Vesanoid
(tretinoin) / Roche
Actemra IV
(tocilizumab) / Roche, JW Pharma
idasanutlin
(RG7388) / Roche
Valcyte
(valganciclovir) / Roche, Mitsubishi Tanabe